High Hopes with South Africa’s New Vaccine Trial

South Africa has launched its largest HIV vaccine trial yet, fueling hope among the many who believe it will take a vaccine to stop the virus despite treatment advances.
 
The vaccine in question, the RV144 combo, demonstrated a modest benefit of about 31% in a trial in Thailand 7 years ago—among a low-risk population. Researchers hope that the study in South Africa, with modifications and an emphasis on a high at-risk population of 5,400 men and women, will prove more successful.
 
The Quote: “If an HIV vaccine were found to work in South Africa, it could dramatically alter the course of the pandemic,” said Glenda Gray, chief executive of the South African Medical Research Council, which is involved in the study.
Source: Sarah Boseley, The Guardian

Comments +

0 comments

Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top